GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other most undervalued healthcare stocks to buy according to analysts. Rising Healthcare Costs and the ...

NOTE: Since the initial appearance of this essay in the 1998 edition of Major Marketing Campaigns Annual, SmithKline Beecham merged with Glaxo to form GlaxoSmithKline plc. The essay continues to refer ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GSK plc, a global healthcare company dedicated to leveraging science, technology, and talent to address disease challenges worldwide.

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

10 each. GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of the UK-based GSK Plc, a global biopharma company, has a legacy in India of nearly 100 years.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...